MedPath

PDT As An Adjunct To SRP In The Management of Chronic Periodontitis

Not Applicable
Conditions
Chronic Periodontitis
Interventions
Procedure: Photodynamic therapy
Registration Number
NCT03770819
Lead Sponsor
KLE Society's Institute of Dental Sciences
Brief Summary

The present study aims to evaluate photodynamic therapy (PDT) using Zinc oxide as a photosensitizer as an adjunct to scaling and root planing (SRP) in the management of chronic periodontitis.

Detailed Description

Following full mouth SRP, each quadrant will be randomly assigned by simple randomization using a computer generated randomization technique into one of the following four treatment modalities.

Group 1 (control) - Application of placebo gel followed by sham PDT (Directing the Light cure device without turning on the light beam).

Group 2 -Application of Zinc oxide gel followed by sham PDT. Group 3 - Application of placebo gel followed by PDT. Group 4 - Application of Zinc oxide gel followed by PDT. The procedure mentioned for each group will be performed on all periodontal pockets in the assigned quadrant at baseline, end of 1 week and 1 month from the first session.

Clinical parameters and microbial profile will be recorded at baseline (before commencement of Periodontal treatment), end of 1 month and end of 3 months following periodontal treatment.

Zinc oxide gel/placebo gel will be placed into the periodontal pockets using a blunt cannula ensuring that starting from the bottom, it completely fills the periodontal pockets. The gel will be retained in the pocket for 5 minutes. The perio tip will be attached to the hand piece of the light cure unit (Wavelength: 420-480nm. Light power: 1200mw/cm2 in continuous mode) and light will be activated for 60 seconds. Following this, the pockets will be irrigated with normal saline solution (0.9%Sodium chloride).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Patients of both genders diagnosed with chronic periodontitis in the age group of 30 to 50 years with good systemic health.
  • Presence of a minimum of 20 teeth and at least one site with probing pocket depth (PPD) of 4-7 mm and clinical attachment level (CAL) of 2 mm or greater, in each of the four quadrants.
Exclusion Criteria
  • Patients who have undergone periodontal therapy during the previous 6 months of commencement of the study.
  • Subjects on antibiotics or immunosuppressant medication 6 months prior to the study.
  • Chronic Smokers, Alcoholics, Smokeless tobacco users.
  • Subjects with acute illnesses/acute intraoral lesions.
  • Pregnant women and lactating mothers.
  • Medically compromised subjects.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo groupPhotodynamic therapyApplication of placebo gel followed by sham Photodynamic therapy
Zinc oxide and PDT groupPhotodynamic therapyApplication of Zinc oxide gel followed by Photodynamic therapy.
Zinc oxide gel groupPhotodynamic therapyApplication of Zinc oxide gel followed by sham Photodynamic therapy.
PDT groupPhotodynamic therapyApplication of placebo gel followed by Photodynamic therapy.
Primary Outcome Measures
NameTimeMethod
Change in Microbial profile3 months

Change in levels of P.gingivalis following PDT

Secondary Outcome Measures
NameTimeMethod
Change in Gingival index score3 months

Change in Gingival index score from Range: 2-3 to Range: 0 to1.9 following PDT

Change in Plaque index score3 months

Change in plaque index score from Range: 2-3 to Range: 0 to1.9 following PDT

Probing pocket depth3 months

Change in probing pocket depth from 5-7 mm to 2.9- 4.2 mm following PDT

Clinical attachment level3 months

Gain in clinical attachment level following PDT

© Copyright 2025. All Rights Reserved by MedPath